1 week ago Minera IRL Provides Corporate Update and Announces Receipt of Failure to File Cease Trade Order

LIMA, Peru, April 10, 2025 (GLOBE NEWSWIRE) — Minera IRL Limited (“Minera”, the “Company” or “we”) (BVL:MIRL) (CSE:MIRL) provides a corporate update and outlines the steps being taken to complete the 2024 audit and file its annual consolidated financial statements, management’s discussion and analysis, annual information form, and the required certifications (the “Annual Filings”). Davidson […]

Economics

1 week ago Constellation Brands Reports Fiscal Year and Fourth Quarter 2025 Financial Results and Fiscal Year 2026 to Fiscal Year 2028 Outlook

ROCHESTER, N.Y., April 09, 2025 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its fiscal year and fourth quarter 2025 financial results and fiscal year 2026 to fiscal year 2028 outlook. A conference call to discuss the financial results and outlook will be hosted by President and Chief […]

Culture

2 w. ago nCino Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Q4 Total Revenues of $141.4M, up 14% year-over-year Fiscal Year 2025 Total Revenues of $540.7M, up 13% year-over-year Q4 Subscription Revenues of $125.0M, up 16% year-over-year Fiscal Year 2025 Subscription Revenues of $469.2M, up 15% year-over-year WILMINGTON, N.C., April 01, 2025 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking […]

Culture

3 w. ago Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2024 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue of Junshi Biosciences was […]

Other

3 w. ago Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025 Reviewing pipeline and development plans for HBV programs Continued focus on efficient deployment of financial resources and personnel – terminated ATM program and implemented reduction of workforce by 57% […]

Culture

3 w. ago Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update

154 patients enrolled TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2024 and provided a corporate update. The Company […]

Culture

3 w. ago The Westaim Corporation Reports Q4 and Full Year 2024 Results and Update on Timing of Proposed Transactions with CC Capital

Note: All dollar amounts in this press release are expressed in U.S. dollars, except as otherwise noted. All share amounts in this press release are after giving effect to the Share Consolidation (as defined herein). The financial results are reported under International Financial Reporting Standards (“IFRS”), except as otherwise noted. TORONTO — The Westaim Corporation […]

Economics

4 w. ago iAnthus Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results

NEW YORK and TORONTO, March 24, 2025 (GLOBE NEWSWIRE) — iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the fourth quarter and year ended December 31, 2024. The Company’s Annual Report on […]

Culture